HHS will divide the remaining $70 billion of financial assistance included in the bipartisan CARES Act to providers and hospitals by 4 tranches, saying the money would also be used to provide care for the uninsured who are ill with coronavirus disease 2019.
HHS will divide the remaining $70 billion of financial assistance included in the bipartisan CARES Act to providers and hospitals by 4 tranches, saying the money would also be used to provide care for the uninsured who are ill with coronavirus disease 2019.
However, HHS Secretary Alex Azar would not provide an estimate of how much of the $70 billion would go toward covering care for those without insurance, only saying that he expected it to be more than enough.
The first $30 billion of the $100 billion in total funds was distributed last week, according to Medicare fee-for-service revenue, which left out many hospitals in the areas hardest hit by the virus, such as New York. The CARES Act, passed in March, gave HHS wide discretion in how to allocate the funds. .
The funds released Wednesday will be apportioned by different criteria than the first wave of funding, HHS said; the formula for disbursement will be proportional to providers' share of 2018 net patient revenue. The funds allocated this way will include $20 billion in payments to a variety of healthcare facilities and providers who were included in the first $30 billion. These funds will begin going out this Friday, HHS said.
HHS said it expects payments to begin next week for these areas:
Azar said additional allocations will be announced for nursing homes, for hospitals and doctors that rely on Medicaid, and for dentists.
As part of the agreement to accept the money, providers and facilities must agree not to balance bill patients who are uninsured, HHS said. It will be up to providers to determine eligibility, Azar added.
The Trump administration, which has resisted calls to reopen the federal marketplace exchanges under the Affordable Care Act for a special enrollment period, is expecting the CARES Act funding to also cover the cost of treating people without insurance.
Earlier this month, the Kaiser Family Foundation published an estimate that pegged the cost of care for uninsured patients at $13.9 billion to $41.8 billion.
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
What We’re Reading: Abortion Privacy Rules; Alzheimer Drug Hurdles; Nursing Home Staffing Overhaul
April 23rd 2024New health privacy rules aim to protect patients and providers in an evolving abortion landscape; some physicians express concerns about efficacy, risks, and entrenched beliefs in treating Alzheimer disease; CMS addresses longstanding staffing deficits in nursing homes.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Survey Results Reveal Potential Factors Slowing the Decline in Cardiovascular Mortality Rate
April 23rd 2024Research indicated that worsened glycemic, blood pressure, and obesity control, as well as increased alcohol consumption, leveled lipid control, and persistent socioeconomic disparities may have contributed to the decelerated cardiovascular mortality decline in recent years.
Read More
Award-Winning Poster Presentations From AMCP 2024
April 23rd 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.
Read More